Breast Cancer Genetic Services in a South African Setting: Proband Testing, Cascading and Clinical Management
Cancer Medicine · 2025
DOI: 10.1002/cam4.70743 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von T S Osler und 6 weiteren Autor:innen. Beteiligte Einrichtung: Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Hauptthemen laut MEDLINE: Breast Neoplasms, Genetic Testing, Genetic Services. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Association of South Africa, Science for Africa Foundation.
Abstract (Originalsprache)
Purpose
Limited data exist on managing hereditary breast cancer in low‐ middle‐income countries (LMICs). We assessed proband and cascade genetic testing, and risk‐reducing measures in a South African regional breast cancer service.
Methods
We analysed records from 534 consecutive female probands receiving genetic counselling for breast cancer and their 115 relatives who attended genetic counselling. Demographic and clinical data, family pedigrees and genetic test data were collated from hospital clinical records, regional laboratory data, screening appointments and radiological records.
Results
Test uptake in probands was high (86.9%), although cost was a deterrent in some. There were 83 (19.6%) probands who tested positive, and 45.0% of them had one or more family members have testing. This resulted in 9.2% of relatives (first‐ to third‐degree) having cascade testing. Family testing was associated with a stronger family history of cancer, female gender and being a first‐degree relative (uptake was 25.6% in female first‐degree relatives). Risk‐reducing mastectomy was accepted by 52.6% of eligible female family members, while mammographic surveillance (30%) and bilateral salpingo‐oophorectomy (15.4%) were less frequent.
Conclusion
Genetic testing was well accepted by probands, but uptake was low in family members. Overall, one family member carrying a pathogenic variant was identified for every 13 probands receiving genetic counselling and for every 11 probands tested. Risk‐reducing measures were taken up by over half of those eligible. Limited uptake of cascade testing and variable uptake of risk‐reducing options impacted the programme. To our knowledge, this is the first study in Africa of the real‐world effectiveness of a breast cancer genetic service.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
- Division of Human Genetics, National Health Laboratory Service and School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
- Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, University of Stellenbosch and Tygerberg Hospital, Cape Town, South Africa.
- Department of Surgery, Charlotte Maxeke Johannesburg Academic Hospital and University of the Witwatersrand, Johannesburg, South Africa.
- Faculty of Medicine and Health Sciences, University of Stellenbosch and Tygerberg Hospital, Cape Town, South Africa.
- Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, University of Stellenbosch and Tygerberg Hospital, Cape Town, South Africa.
ORCID-Profile: T S Osler
Förderung
- Cancer Association of South Africa
- Science for Africa Foundation
Zitieren
APA
Osler, T. S., Schoeman, M., Edge, J., Pretorius, W. J. S., Rabe, F. H., Mathew, C. G., & Urban, M. F. (2025). Breast Cancer Genetic Services in a South African Setting: Proband Testing, Cascading and Clinical Management. Cancer Medicine. https://doi.org/10.1002/cam4.70743
Vancouver
Osler TS, Schoeman M, Edge J, Pretorius WJS, Rabe FH, Mathew CG, et al. Breast Cancer Genetic Services in a South African Setting: Proband Testing, Cascading and Clinical Management. Cancer Medicine. 2025. doi:10.1002/cam4.70743
BibTeX
@article{Osler2025,
author = {Osler, T S and Schoeman, M and Edge, J and Pretorius, W J S and Rabe, F H and Mathew, C G and Urban, M F},
title = {Breast Cancer Genetic Services in a South African Setting: Proband Testing, Cascading and Clinical Management},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70743}
}
EUVIMED